Please create a page that is using page template "Property Comparison".
You have reached the maximum of four properties per comparison.
Dear Entrepreneurs, We are pleased to announce our partnership with the Raleigh Innovators Program. The signature 12-week Innovators Program embraces core principles of Design Thinking, Lean Startup and Modern Leadership to enable both early-stage startups and corporate teams to rapidly test and validate their business models in the market. The Cherokee-McDonough Challenge will be sponsoring the clean technology track, which will allow three clean technology startups to join the 2015 cohort of software startups in the small to large enterprise space. All startups that successfully complete the program will be awarded a $25,000 grant. For more information, click here. Best, Cherokee-McDonough Challenge Team
Liquid Private Equity – A New, “Old Way” to Invest Technology has dramatically changed the way we invest. Today, the focus of sophisticated investors is on massive diversification through the use of multiple asset classes across a variety of funds, with the dual goals of mitigating risk and reducing the costs and fees associated with investing. While providing smoother and more predictable results over a long period of time, this approach makes it difficult to capitalize on special opportunities in financial markets. In the past, investors bought shares of specific, individual companies that were poised to grow, prosper, and of course provide returns. This paradigm has shifted significantly. Today, investors typically hire firms who, in turn, employ multiple third-party investment managers, resulting in a portfolio of dozens, if not hundreds, of securities. Investors are left wondering: “What am I actually investing in?” At Anchor Capital, we invest in companies – not stocks. This is why we call our strategy “a new, ‘old way’ to invest.” Our liquid private equity strategy whittles down the universe of small public companies, uncovering a handful that are undervalued and poised for extraordinary growth. The Anchor Capital team – former business executives of both private and public companies – knows what to look for in potential investments. Anchor evaluates investment opportunities based on intensive fundamental research with a view toward long-term intrinsic value. The result is a selective portfolio of outstanding companies, minimal trading activity, and a proven track record of success.
The Venture Capital Movement is dedicated to accelerating Start-up Ready Individuals capable of exploring the technology industry as part of start-ups, venture capitalist funds or other organisations that support start-ups. Founded in 2014 as a non-profit and independent student society, our mission is to engage students within university campuses across London on the role of venture capitalists in developing start-ups. Supported by the British Private Equity and Venture Capital Association (BVCA); the industry body and public policy advocate for the venture capital and private equity industry in the United Kingdom. Our growing team of students from University College London and the London School of Economics & Political Science also has strong links with organisations on campus. We were featured in Singapore The Straits Times and UCL School of Management for our programs. (Click on the respective images to read on articles)
At Franklin Street Partners, we combine perspective on the financial markets with a deep understanding of the goals of our clients, whether individuals, multi-generational families, foundations or institutions. Because we are privately owned, our perspective is our own. And because we make a fiduciary commitment to each client, your interests are the driving force in each investment decision we make.
Morgan Creek Capital Management, LLC is a SEC-registered investment adviser providing investment management services to institutions and wealthy families. We provide a customized investment solution to clients in need of a targeted investment program, as well as discretionary strategies to assist clients in building investment programs based on the University Endowment Model. We provide asset allocation, manager selection, and portfolio construction.
NDI is a hybrid venture capital and commercialization firm focusing exclusively on innovative neurodevice technologies that are intended to restore lost neurological function, prevent damage and reduce the painful effects of disease and injury. NDI provides the capital to: • Identify and develop technologies • Launch and grow companies • Take them to successful exits
WHO WE ARE From offices in Durham, Portland and Seattle, Echo Health Ventures invests in, builds and grows tomorrow’s great health care companies. We work with our portfolio companies to accelerate their innovations to scale nationally. As stage-agnostic investors, we are committed to a new approach to strategic investing – an approach that brings more than capital to the table, an approach focused on developing deep, high-value relationships with our portfolio companies.
CONCENTRATED ACCESS. We believe success in venture capital is limited to a small group of elite managers. We have the experience, relationships, and operating model to build fund-of-funds portfolios specifically structured to provide high concentration to these elite managers. We seek to invest in top-tier, access-constrained venture funds and strive to be value-added limited partners in a true partnership model. We pride ourselves on thinking differently, adapting quickly, and thematically investing in only the best. The funds in which we invest are redefining creativity, recreating stale sectors, and re-imagining what it means to innovate. DIRECT EXPOSURE. We seek to leverage our relationships with top tier venture firms to source expansion and later stage direct deal opportunities in companies we believe have demonstrated market traction. We seek to invest in companies with what we believe to be high quality management teams and differentiated products in growth markets. We believe the investment team’s years of direct venture capital investment experience allows us to lead and price a majority of our direct transactions, but we maintain the flexibility to participate in transactions led by other firms as well.
About Us We invest in ventures that commercialize or develop technology and inventions of UNC faculty, trainees and staff. Our Vision To ensure that startups and other University-sourced companies have the opportunity to fully develop and deploy technology generated here, UNC-Chapel Hill launched Carolina Research Ventures (CRV). CRV has created an early stage investment fund (the Fund or CRVF) to provide critical discovery and development capital. The goal of the CRVF is to unlock the potential of UNC-Chapel Hill technologies and advance the commercialization of these technologies by providing early-stage capital and industry expertise. Who We Are CRV is overseen by a Board of Directors composed of entrepreneurs, researchers, scientists, and investment professionals. By charter the Board must include two appointees from the UNC-Chapel Hill Board of Trustees, two appointees from the UNC Healthcare System, the University Vice Chancellor for Finance, the CEO of the UNC Management Company or their designee, and three at-large positions elected by the other Board members. In addition, the Vice Chancellor for Commercialization and Economic Development is a Board observer. The Fund is managed as a joint venture with Hatteras Venture Partners. A team from Hatteras, including Clay Thorp, Christy Shaffer, PhD, and Michael Dial, PhD, will oversee the operations of the Fund and its investment portfolio. Michael Dial is the lead Hatteras member for the Fund. Additional information about the Hatteras team can be found at www.hatterasvp.com
BioInnovation Capital invests in the most promising life science companies in residence at premier co-working laboratory facilities where our partners are on-site every day. As the first investment platform to knit together a national network of co-working laboratories, we have a unique lens and an unparalleled position from which to invest. Our partners are located in: Cambridge, MA (BioLabs and LabCentral); Durham, North Carolina (BioLabs North Carolina); San Francisco, CA (QB3@953); and San Diego, CA (BioLabs San Diego). Our perspective is characterized by superb access to key innovators in academia, as well as to the corporate partners who are likely eventual homes for our investments. The geographic nature of innovation hubs and our overlapping network of facilities and resources, supports the formation of stellar companies from the most powerful universities, research institutions, hospitals and corporations in our sector.
This is a call to action for realtors, professionals and vacation rental managers/owners to create the largest FREE
real estate database and community in the world. Once there are enough posts, you will see national
advertising directing customers to your listings and professional profiles.
For a limited time, every new member who signs up and every post entered will earn the opportunity to win a new iphone 7.
For example: A realtor joins reignlist.com as a new member (1 chance), creates a professional profile (1 chance) and posts 5 listings (5 chances), will have a total of 7 chances to win. See terms and conditions